Apollo Medical Holdings Inc
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health … Read more
Apollo Medical Holdings Inc (3AM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.018x
Based on the latest financial reports, Apollo Medical Holdings Inc (3AM) has a cash flow conversion efficiency ratio of 0.018x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€9.96 Million) by net assets (€554.72 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Apollo Medical Holdings Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Apollo Medical Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Apollo Medical Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apollo Medical Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sunvim Group Co Ltd
SHE:002083
|
0.023x |
|
Qurient Co. Ltd
KQ:115180
|
-0.062x |
|
Beijing Philisense Tech
SHE:300287
|
-0.021x |
|
Suzhou Good-Ark Electronics Co Ltd
SHE:002079
|
0.026x |
|
Guangdong Goworld Co Ltd
SHE:000823
|
0.049x |
|
Tellurian Inc
F:MPLN
|
-0.062x |
|
Viad Corp
NYSE:VVI
|
0.569x |
|
Hongta Securities Co Ltd
SHG:601236
|
0.070x |
Annual Cash Flow Conversion Efficiency for Apollo Medical Holdings Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Apollo Medical Holdings Inc from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €514.17 Million | €52.20 Million | 0.102x | -38.88% |
| 2023-12-31 | €410.77 Million | €68.23 Million | 0.166x | +12.96% |
| 2022-12-31 | €558.55 Million | €82.13 Million | 0.147x | +6.75% |
| 2021-12-31 | €510.64 Million | €70.33 Million | 0.138x | +32.82% |
| 2020-12-31 | €445.15 Million | €46.16 Million | 0.104x | -22.42% |
| 2019-12-31 | €361.06 Million | €48.27 Million | 0.134x | +113.21% |
| 2018-12-31 | €406.66 Million | €25.50 Million | 0.063x | -- |